Categories: News

Boosh Plant-Based Brands Receives FINRA Clearance Letter; Submits OTCQB(R) Application

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Vancouver, British Columbia–(Newsfile Corp. – July 6, 2021) – Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTC Pink: VGGIF) (“Boosh” or the “Company”) announces that on Monday June 28th the Company submitted its application to have its common stock quoted on the OTCQB® market maintained by OTC Markets, Inc. On July 1st, the Company received notice that its market maker in the U.S. had received clearance from FINRA to initiate a quotation, and thus its common stock is now quoted on the OTCPink market maintained by OTC Markets, Inc. as “VGGIF”. The Company will provide an update on its DTC eligibility and the outcome of its OTCQB® application as available.

In other news the Company issued 10,000 Employee Stock Options (“Options”) to Maria Hussaini the Company’s CFO and Marion Mcgrath the Company’s corporate secretary, respectively. The price of the Options are $1.10 and was based on the close of trading on July 5th.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (833) 882-6674

Investor Relations
Contact – Edge Communications Group
Email: invest@booshfood.com
Telephone: (236) 237-1315

About Boosh Plant-Based Brands Inc.:

Boosh Plant-Based Brands Inc., through its wholly owned subsidiary, Boosh Food, is the gateway to experiencing high quality, non-GMO, gluten free, 100% plant-based nutritional comfort foods for the whole family. We currently offer six frozen meals which are sold throughout Canada, and in the summer will be expanding our meals to include three refrigerated products. Boosh, good for you and good for planet earth.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to, the Company’s proposed use of the proceeds of its initial public offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/89474

Staff

Recent Posts

Hisense Unveils Latest AI-Driven Innovations at AWE 2025, Pioneering a New Era of Smart Living

DUBAI, UAE, March 27, 2025 /PRNewswire/ -- Hisense, a leading global consumer electronics brand showcased…

2 hours ago

DeepCare Unveils Game-Changing Dental AI Agent at IDS 2025

COLOGNE, Germany, March 27, 2025 /PRNewswire/ -- From March 25 to 29, 2025, DeepCare, a global…

2 hours ago

Ventra Health Launches Strategic Partnership with Radix Health to Offer Independent Dispute Resolution to Providers

DALLAS, March 26, 2025 /PRNewswire/ -- Ventra Health ("Ventra"), a leading business solutions provider for facility-based…

8 hours ago

Zepp Health Corporation Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

MILPITAS, Calif., March 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:…

14 hours ago

CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment

A global collaboration agreement has been signed for the development and commercialization of a Granzyme…

14 hours ago